Methylphenidate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

11 API Suppliers, 5 USDMF, 1 EU WC, 5 NDC API, 7 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

INTERMEDIATES

17 API Suppliers

17 API Suppliers

FINISHED DOSAGE FORMULATIONS

119 FDF Dossiers, 14 FDA Orange Book, 56 Europe, 24 Australia, 16 South Africa, 9 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - 17.3MG, TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - 25.9MG, TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - 8.6MG

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 14 SPI Pharma, 2 Seqens, 1 DKSH, 1 Pharm-RX Chemical, 4 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 3 Actylis, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 14 BASF, 1 Bioplus Life Sciences, 6 Corel Pharma Chem, 2 DFE Pharma, 3 Doshion Polyscience, 1 Finar, 7 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 6 Kerry, 1 Kima Chemical, 10 Microlex e.U, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 3 Pluviaendo, 2 Prachin Chemical, 10 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 8 Sigachi Industries, 1 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

42 Fillers, Diluents & Binders, 28 Direct Compression, 19 Taste Masking, 19 Thickeners and Stabilizers, 16 Disintegrants & Superdisintegrants, 15 Granulation, 14 Chewable & Orodispersible Aids, 12 Coating Systems & Additives, 12 Controlled & Modified Release, 11 Co-Processed Excipients, 11 Lubricants & Glidants, 7 Parenteral, 7 Film Formers & Plasticizers, 7 Solubilizers, 7 Topical, 3 Emulsifying Agents, 2 API Stability Enhancers, 1 Surfactant & Foaming Agents, 1 Rheology Modifiers